An Early Increase in IL-10 and TNF-α Levels Following Atezolizumab Plus Bevacizumab Treatment Predicts Survival in Advanced Hepatocellular Carcinoma Patients: A Prospective Cohort Study.

Autor: Lee, Soon Kyu1 (AUTHOR) blackiqq@catholic.ac.kr, Nam, Soon Woo1 (AUTHOR) drswnam@catholic.ac.kr, Han, Ji Won2 (AUTHOR) tmznjf@catholic.ac.kr, Kwon, Jung Hyun1 (AUTHOR) doctorkwon@catholic.ac.kr
Zdroj: Cancers. Oct2024, Vol. 16 Issue 20, p3543. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje